| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | MTD Mettler Toledo International Inc/ | Filliol Olivier A71 | Director | Sell | 6,448 | $1,491.20 | $9,615,268.45 | -12.8% | -4.9% | -25.9% | |
| Dec 1, 2022 | WGS Genedx Holdings Corp. | Meister Keith A.63 | Director | Sell | 6,789,360 | $0.40 | $2,708,954.64 | -25.2% | +18.8% | -86.3% | |
| Dec 1, 2022 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 6,409 | $224.25 | $1,437,204.80 | -8.7% | -1.5% | -10.8% | |
| Dec 1, 2022 | A Agilent Technologies, Inc. | Thaysen Jacob67 | Sr. Vice President | Sell | 12,935 | $154.89 | $2,003,439.72 | -7.0% | -11.9% | -17.5% | |
| Dec 1, 2022 | XWEL Xwell, Inc. | Bernstein Bruce58 | Director | Buy | 50,000 | $0.42 | $21,097.25 | +3.4% | -6.5% | -71.9% | |
| Nov 30, 2022 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 685 | $34.39 | $23,559.34 | -0.2% | -9.6% | -24.0% | |
| Nov 30, 2022 | WAT Waters Corp /de/ | Conard Edward | Director | Sell | 1,059 | $334.70 | $354,447.30 | -1.4% | -10.3% | -19.0% | |
| Nov 29, 2022 | MTD Mettler Toledo International Inc/ | Filliol Olivier A71 | Director | Sell | 10,252 | $1,420.65 | $14,564,514.85 | -16.9% | +1.4% | -22.6% | |
| Nov 29, 2022 | CSTL Castle Biosciences Inc | Olson Tiffany | Director | Buy | 1,162 | $21.50 | $24,983.00 | +64.3% | +13.2% | -9.2% | |
| Nov 28, 2022 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Buy | 185,185 | $0.54 | $99,999.90 | New | +5.6% | -87.8% | |
| Nov 28, 2022 | DHR Danaher Corp /de/ | Weidemanis Joakim67 | Executive Vice President | Sell | 9,508 | $266.60 | $2,534,877.52 | -6.1% | -5.1% | -16.2% | |
| Nov 23, 2022 | A Agilent Technologies, Inc. | Gonsalves Rodney65 | V.p., Corporate Controller | Sell | 4,634 | $156.20 | $723,830.80 | -14.0% | -7.7% | -18.5% | |
| Nov 23, 2022 | A Agilent Technologies, Inc. | Fields Heidi | Director | Sell | 3,635 | $155.84 | $566,482.04 | -6.3% | -7.7% | -18.5% | |
| Nov 23, 2022 | NDRA Endra Life Sciences Inc. | Tokman Alexander Y | Director | Buy | 10,000 | $0.17 | $1,700.00 | +6.5% | +11.3% | -69.7% | |
| Nov 22, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 300,000 | $1.49 | $446,672.97 | - | -25.9% | +4.1% | |
| Nov 22, 2022 | A Agilent Technologies, Inc. | Tang Michael61 | SVP, General Counsel, And Sec. | Sell | 7,545 | $153.90 | $1,161,175.50 | -14.0% | -8.6% | -21.0% | |
| Nov 22, 2022 | A Agilent Technologies, Inc. | McDonnell Padraig71 | Sr. Vice President | Sell | 2,746 | $153.21 | $420,714.66 | -14.5% | -8.6% | -21.0% | |
| Nov 22, 2022 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 128,726 | $155.73 | $20,046,499.98 | -33.1% | -8.6% | -21.0% | |
| Nov 22, 2022 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,958 | $20.76 | $185,940.90 | -0.7% | +12.7% | -5.8% | |
| Nov 21, 2022 | MTD Mettler Toledo International Inc/ | De La Guerroniere Marc56 | Head Of Eur &Na Market Orgs | Sell | 2,101 | $1,397.81 | $2,936,806.31 | -69.4% | +4.8% | -22.0% | |
| Nov 21, 2022 | TWST Twist Bioscience Corp | Banyai William81 | See Remarks | Sell | 1,275 | $24.90 | $31,747.50 | -0.5% | -19.8% | -7.4% | |
| Nov 21, 2022 | BDSX Biodesix Inc | Massarany Hany | Director | Buy | 130,434 | $1.15 | $149,999.10 | +1,739% | +76.9% | +1.5% | |
| Nov 21, 2022 | BDSX Biodesix Inc | Kennedy Lawrence T. Jr | 10% Owner | Buy | 10,869,565 | $1.15 | $12,499,999.75 | +412.5% | +76.9% | +1.5% | |
| Nov 21, 2022 | BDSX Biodesix Inc | Watts Charles M | Director | Buy | 43,478 | $1.15 | $49,999.70 | +553.5% | +76.9% | +1.5% | |
| Nov 21, 2022 | BDSX Biodesix Inc | Patience John | Director, 10% Owner, Chairman | Buy | 1,739,130 | $1.15 | $1,999,999.50 | +61.9% | +76.9% | +1.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.